Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002910150 | SCV003264890 | likely benign | Ullrich congenital muscular dystrophy 2; Bethlem myopathy 2 | 2022-12-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004614268 | SCV005108829 | uncertain significance | Inborn genetic diseases | 2024-03-28 | criteria provided, single submitter | clinical testing | The c.9143A>C (p.Q3048P) alteration is located in exon 65 (coding exon 64) of the COL12A1 gene. This alteration results from a A to C substitution at nucleotide position 9143, causing the glutamine (Q) at amino acid position 3048 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |